190 related articles for article (PubMed ID: 16357573)
1. The significance of beta2-adrenergic receptor polymorphisms in asthma.
Litonjua AA
Curr Opin Pulm Med; 2006 Jan; 12(1):12-7. PubMed ID: 16357573
[TBL] [Abstract][Full Text] [Related]
2. β(2) -adrenoreceptor polymorphisms in asthmatic and non-asthmatic schoolchildren from Colombia and their relationship to treatment response.
Isaza C; Sepúlveda-Arias JC; Agudelo BI; Arciniegas W; Henao J; Porras GL; Beltrán L
Pediatr Pulmonol; 2012 Sep; 47(9):848-55. PubMed ID: 22328447
[TBL] [Abstract][Full Text] [Related]
3. Analysis of ADRB2 (Arg16Gly) Gene Variant with Susceptibility, Pharmacogenetic Response and Disease Severity in South Indian Asthmatics.
Bandaru S; Akka J; Marri VK; Alvala M; Ponnala D; Mundluru HP
Inflammation; 2015 Dec; 38(6):2146-55. PubMed ID: 26071206
[TBL] [Abstract][Full Text] [Related]
4. beta2-Adrenergic receptor polymorphisms and asthma in the North Indian population.
Bhatnagar P; Gupta S; Guleria R; Kukreti R
Pharmacogenomics; 2005 Oct; 6(7):713-9. PubMed ID: 16207148
[TBL] [Abstract][Full Text] [Related]
5. Beta 2 Adrenergic Receptor Genetic Polymorphisms in Bronchial Asthma: Relationship to Disease Risk, Severity, and Treatment Response.
Mohamed-Hussein AAR; Sayed SS; Eldien HMS; Assar AM; Yehia FE
Lung; 2018 Dec; 196(6):673-680. PubMed ID: 30178312
[TBL] [Abstract][Full Text] [Related]
6. Beta-2 adrenergic receptor (ADRB2) gene polymorphisms and the risk of asthma: a meta-analysis of case-control studies.
Liang SQ; Chen XL; Deng JM; Wei X; Gong C; Chen ZR; Wang ZB
PLoS One; 2014; 9(8):e104488. PubMed ID: 25111792
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine.
Ortega VE; Meyers DA
J Allergy Clin Immunol; 2014 Jan; 133(1):16-26. PubMed ID: 24369795
[TBL] [Abstract][Full Text] [Related]
8. An investigation of the association between ADRB2 gene polymorphisms and asthma in Kazakh population.
Akparova A; Aripova A; Abishev M; Kazhiyakhmetova B; Pirmanova A; Bersimbaev R
Clin Respir J; 2020 Jun; 14(6):514-520. PubMed ID: 32034992
[TBL] [Abstract][Full Text] [Related]
9. ADRB2 polymorphisms and asthma susceptibility: transmission disequilibrium test and meta-analysis.
Migita O; Noguchi E; Jian Z; Shibasaki M; Migita T; Ichikawa K; Matsui A; Arinami T
Int Arch Allergy Immunol; 2004 Jun; 134(2):150-7. PubMed ID: 15153795
[TBL] [Abstract][Full Text] [Related]
10. Family-based association analysis of beta2-adrenergic receptor polymorphisms in the childhood asthma management program.
Silverman EK; Kwiatkowski DJ; Sylvia JS; Lazarus R; Drazen JM; Lange C; Laird NM; Weiss ST
J Allergy Clin Immunol; 2003 Nov; 112(5):870-6. PubMed ID: 14610472
[TBL] [Abstract][Full Text] [Related]
11. Role of ADRB2 gene polymorphism in asthma and response to beta(2)-agonists in Polish children.
Szczepankiewicz A; Breborowicz A; Sobkowiak P; Kramer L; Popiel A
J Appl Genet; 2009; 50(3):275-81. PubMed ID: 19638684
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of the association of beta2-adrenergic receptor polymorphisms with asthma phenotypes.
Contopoulos-Ioannidis DG; Manoli EN; Ioannidis JP
J Allergy Clin Immunol; 2005 May; 115(5):963-72. PubMed ID: 15867853
[TBL] [Abstract][Full Text] [Related]
13. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.
Bleecker ER; Postma DS; Lawrance RM; Meyers DA; Ambrose HJ; Goldman M
Lancet; 2007 Dec; 370(9605):2118-25. PubMed ID: 18156033
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of inhaled long-acting beta2-agonists in asthma: A systematic review.
Slob EMA; Vijverberg SJH; Palmer CNA; Zazuli Z; Farzan N; Oliveri NMB; Pijnenburg MW; Koppelman GH; Maitland-van der Zee AH
Pediatr Allergy Immunol; 2018 Nov; 29(7):705-714. PubMed ID: 29992699
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of the influence of ADRB2 genetic polymorphisms on albuterol (salbutamol) therapy in patients with asthma.
Hikino K; Kobayashi S; Ota E; Mushiroda T; Urayama KY; Kobayashi T
Br J Clin Pharmacol; 2021 Apr; 87(4):1708-1716. PubMed ID: 32986886
[TBL] [Abstract][Full Text] [Related]
16. Association between genetic polymorphisms of beta2 adrenergic receptors and nocturnal asthma in Egyptian children.
Karam RA; Sabbah NA; Zidan HE; Rahman HM
J Investig Allergol Clin Immunol; 2013; 23(4):262-6. PubMed ID: 23964556
[TBL] [Abstract][Full Text] [Related]
17. Role of
Scaparrotta A; Franzago M; Marcovecchio ML; Di Pillo S; Chiarelli F; Mohn A; Stuppia L
J Aerosol Med Pulm Drug Deliv; 2019 Jun; 32(3):164-173. PubMed ID: 30855197
[No Abstract] [Full Text] [Related]
18. Home dampness, beta-2 adrenergic receptor genetic polymorphisms, and asthma phenotypes in children.
Wang IJ; Tsai CH; Kuo NW; Chiang BL; Tung KY; Lee YL
Environ Res; 2012 Oct; 118():72-8. PubMed ID: 22883364
[TBL] [Abstract][Full Text] [Related]
19. Acute and chronic lung function responses to salmeterol and salmeterol plus fluticasone propionate in relation to Arg16Gly beta(2)-adrenergic polymorphisms.
Yancey SW; Klotsman M; Ortega HG; Edwards LD; Anderson WH
Curr Med Res Opin; 2009 Apr; 25(4):1011-8. PubMed ID: 19275519
[TBL] [Abstract][Full Text] [Related]
20. Beta2-adrenoceptor polymorphisms and asthma from childhood to middle age in the British 1958 birth cohort: a genetic association study.
Hall IP; Blakey JD; Al Balushi KA; Wheatley A; Sayers I; Pembrey ME; Ring SM; McArdle WL; Strachan DP
Lancet; 2006 Aug; 368(9537):771-9. PubMed ID: 16935688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
